Cure My Disease

Don't miss your cure!

 Log in / Sign up

Targeting hidden balance issues: a new therapy for early MS

NCT ID NCT07805733

Symptom relief Sponsor: LIFE - Research and Care Institute - Santa Lucia IRCCS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 04, 2026 · Last updated Sep 04, 2026

Summary

This trial tests whether a specialized form of physical therapy, called vestibular physical therapy, can improve balance in people with early multiple sclerosis (MS) who have mild disability but still feel unsteady. Participants will be randomly assigned to receive the therapy or standard care, then switch after a washout period. Researchers will use brain scans (fMRI) and wearable sensors to measure changes in balance, gait, and brain activity, aiming to develop a personalized training approach.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Vestibular physical therapy, a structured 12-session program focusing on visuo-vestibular integration and sensory reweighting
What this could lead to
If it works, this could lead to a personalized balance training program that helps people with early multiple sclerosis maintain mobility and confidence, potentially preventing falls and disability.
What could go wrong
This is a small, early-stage trial with only 30 participants, so results may not apply to everyone with MS. The therapy might not improve balance for all, and MRI and gait measures may not capture meaningful changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Oct 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * people with Relapsing-Remitting Multiple Sclerosis; * All participants must be ambulatorial (EDSS ≤2.5); Exclusion Criteria: * relapse or medication changes in the prior 6 months; * people with peripheral vestibular disorders; * people with contraindications to MRI. We will also recruit 30 healthy volunteers, matched for age and sex, who will complete the assessment protocol once, to serve as a comparison group for individuals with MS.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis relapsing-remitting multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Multiple sclerosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.